Ibusta

Barnidipine Hydrochloride, the active ingredient in Ibusta, is a calcium channel blocker presented as a tablet for oral use. It is used to treat essential hypertension in adult patients. GNH USA supplies Ibusta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Barnidipine Hydrochloride is indicated for conditions related to elevated blood pressure within the hypertension disease family.

Essential hypertension: lowers systolic and diastolic blood pressure in patients with primary high blood pressure. Primary hypertension: provides sustained antihypertensive effect for adults with non‑secondary hypertension. Isolated systolic hypertension: reduces elevated systolic pressure, especially in elderly patients.

Barnidipine Hydrochloride may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially after standing. - Flushing or warmth sensation. - Peripheral edema: swelling of ankles or feet. - Fatigue or general weakness. - Tachycardia: increased heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Allergic reactions: rash, itching, or swelling. - Liver dysfunction: elevated enzymes or jaundice. - Cardiac conduction disturbances: heart block or arrhythmias. - Angioedema: swelling of lips, tongue, or airway. - Renal impairment: sudden decrease in kidney function.

Before initiating therapy with Barnidipine Hydrochloride, consider the following precautions. - Renal impairment: monitor kidney function and adjust therapy as needed. - Hepatic impairment: use with caution and observe liver enzymes. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Concomitant antihypertensives: increased risk of excessive blood pressure lowering. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Barnidipine Hydrochloride can interact with several drug classes. Review the following interaction categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise plasma levels. - Other calcium channel blockers: additive vasodilatory effect leading to hypotension. - Grapefruit juice: can increase drug exposure and risk of adverse events.

Moderate Interactions (Monitor Closely): - Diuretics: enhanced antihypertensive effect, monitor electrolytes. - ACE inhibitors or ARBs: combined effect may cause excessive blood pressure drop. - Beta‑blockers: monitor heart rate and signs of bradycardia. - NSAIDs: may attenuate antihypertensive response. - Antidiabetic agents: possible enhancement of glucose‑lowering effect.